Welcome to the UroVysion website, brought to you by Abbott Molecular. The UroVysion website aims to provide a wealth of valuable information for patients, clinicians, and laboratory professionals related to bladder cancer and the UroVysion molecular test.
UroVysion is the only FDA-approved FISH kit included in the 2013 NCCN guidelines.
“Consideration may be given to FDA-approved urinary biomarker testing by fluorescence in situ hybridization (FISH) or nuclear matrix protein 22 (NMP22) for monitoring for recurrence.”
References:Kamat et al., J Urol. 2012; 187: 862-867
April 8-9, May 6-7, June 3-4
July 8-9, August 5-6, September 9-10
October 7-8, November 4-5, December 2-3